Sydney, Australia, Nov 16, 2006 - (JCN Newswire) - Apollo Life Sciences Ltd (ASX: AOP) announced today that initial studies showed two of its human proteins outperform competitor proteins in stimulating faster growth in numbers of blood-producing stem cells, which are mainly used to generate white blood cells for chemotherapy patients.
